3-氯苄胺盐酸盐 | 24095-60-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氯苄胺盐酸盐
• 中文别名: 3-氯苄脒盐酸盐；3-氯苯甲脒盐酸盐；间氯苯脒盐酸盐
• 英文名称: 3-chlorobenzamidine hydrochloride
• 英文别名: 3-chlorobenzimidamide hydrochloride；3-chlorobenzenecarboximidamide hydrochloride；3-chlorobenzenecarboximidamide;hydrochloride
• CAS: 24095-60-1
• 化学式: C₇H₇ClN₂*ClH
• mdl: MFCD00276754
• 分子量: 191.06
• InChiKey: KWDHABCUIIRLJP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  49.9
• 氢给体数：
  3
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2925290090
• 危险性防范说明：
  P280,P305+P351+P338,P310
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  室温且干燥环境下使用。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Chlorobenzamidine HCl
Synonyms: 3-Chlorobenzene-1-carboximidamide hydrochloride

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Chlorobenzamidine HCl
CAS number: 24095-60-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H7ClN2.ClH
Molecular weight: 191.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氯苄胺盐酸盐 在 碘 、 caesium carbonate 作用下， 以 邻二氯苯 为溶剂， 反应 16.0h， 以73%的产率得到3,5-bis(3-chlorophenyl)-1H-1,2,4-triazole
  参考文献：
  名称：

  I 2介导的由idine和酰亚胺形成的一锅合成1,2,4-三唑

  摘要：

  已经描述了使用I 2 / Cs 2 CO 3一锅法容易地合成3,5-二取代-1 H -1,2,4-三唑衍生物。该方法涉及容易获得的廉价试剂，并且适用于多种底物。该转化涉及高产率和高选择性的一锅顺序C–N和N–N键形成反应，并为合成3,5-二取代-1 H -1,2,4-提供了新的有用策略三唑衍生物。

  DOI：

  10.1016/j.tetlet.2016.04.015
• 作为产物：
  描述：

  3-氯苯腈 在 氯化铵 作用下， 反应 72.0h， 生成 3-氯苄胺盐酸盐
  参考文献：
  名称：

  以卤二氮杂环为卤碳烯前体的连续流中烯烃的环丙烷化反应

  摘要：

  据报道，通过烯烃与氯二氮丙啶光解产生的氯卡宾反应制备取代的3-氯-3-芳基-环丙烷是一种有效的方法。这种方法有助于在发光二极管 (LED) 照射的影响下以 5 分钟的停留时间连续流动生产各种 3-氯-3-芳基-环丙烷（32 个实例）。 380 nm 照射条件的使用有效地扩展到取代的 3-溴-3-芳基-环丙烷的合成（3 个示例）。

  DOI：

  10.1002/chem.202303969

文献信息

• A Concise and Efficient Approach to 2,6-Disubstituted 4-Fluoro­pyrimidines from α-CF3 Aryl Ketones
  作者：Fangran Liu、Xiaofei Zhang、Qun Qian、Chunhao Yang

  DOI：10.1055/s-0039-1690248

  日期：2020.1

  Herein, a concise and efficient protocol to synthesize a series of 2,6-disubstituted 4-fluoropyrimidines as universal and useful building blocks in medicinal chemistry is reported. From readily accessible α-CF3 aryl ketones and different amidine hydrochlorides, this method provides a very practical approach to this kind of compounds under mild conditions with good to excellent yields.

  在本文中，报告了一种简明有效的方案，用于合成一系列2,6-二取代的4-氟嘧啶，作为药物化学中通用的和有用的构建基块。从容易获得α-CF 3芳基酮和不同脒盐酸盐，该方法提供对这种具有良好到优异的产率在温和条件下的化合物的非常实用的方法。
• [EN] 4-AMINO SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS AS PDE4 INHIBITORS<br/>[FR] COMPOSÉS PYRIMIDINES CONDENSÉS 4-AMINO SUBSTITUÉS EN TANT QU'INHIBITEURS DE PDE4
  申请人：GRUENENTHAL GMBH

  公开号：WO2014117947A1

  公开（公告）日：2014-08-07

  The invention relates to novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.

  这项发明涉及一种新型的取代的紧凑嘧啶化合物，其一般式为（I），其中化学基团、取代基和指数如描述中所定义，并且涉及它们作为药物的用途，特别是作为用于通过抑制PDE4酶治疗可治疗的疾病和病症的药物。
• Carbon Atom Insertion into Pyrroles and Indoles Promoted by Chlorodiazirines
  作者：Balu D. Dherange、Patrick Q. Kelly、Jordan P. Liles、Matthew S. Sigman、Mark D. Levin

  DOI：10.1021/jacs.1c06287

  日期：2021.8.4

  calculations supporting a selectivity-determining cyclopropanation step. Computations surprisingly indicate that the stereochemistry of cyclopropanation is of little consequence to the subsequent electrocyclic ring opening that forges the pyridine core, due to a compensatory homoaromatic stabilization that counterbalances orbital-controlled torquoselectivity effects. The utility of this skeletal transform is

  在这里，我们报告了一种反应，该反应通过将芳基羰基阳离子等价物分别插入吡咯和吲哚核心选择性地产生 3-芳基吡啶和喹啉基序。通过使用 α-chlorodiazirines 作为相应氯卡宾的热前体，可以修改作为母体 Ciamician-Denstedt 重排核心的传统基于卤仿的协议，以直接提供 3-（杂）芳基吡啶和喹啉。通过氧化可商购的脒鎓盐可方便地在一个步骤中制备氯二氮嗪。检测了作为吡咯取代模式函数的选择性，并提出了基于空间效应的预测模型，DFT 计算支持确定选择性的环丙烷化步骤。计算出人意料地表明，环丙烷化的立体化学对随后形成吡啶核心的电环开环几乎没有影响，这是由于补偿性同芳族稳定化抵消了轨道控制的扭矩选择性效应。通过喹啉的制备和药学相关吡咯的骨架编辑进一步证明了这种骨架转化的效用。
• DPP IV inhibitors
  申请人：——

  公开号：US20030130281A1

  公开（公告）日：2003-07-10

  The present invention relates to compounds of formula (I) 1 wherein R 1 , R 2 , and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.

  本发明涉及以下式（I）的化合物： 其中R1、R2和X如描述和权利要求中所定义，并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与DPP IV相关的疾病，如糖尿病，特别是非胰岛素依赖型糖尿病和糖耐量受损。
• [EN] 4-PHENYL-N-(PHENYL)THIAZOL-2-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS<br/>[FR] DÉRIVÉS DE 4-PHÉNYL-N-(PHÉNYL)THIAZOL-2-AMINE ET COMPOSÉS ASSOCIÉS UTILISÉS COMME AGONISTES DU RÉCEPTEUR D'HYDROCARBURE ARYLE (AHR) POUR LE TRAITEMENT, PAR EX., DE TROUBLE LIÉS À L'ANGIOGENÈSE OU INFLAMMATOIRES
  申请人：IKENA ONCOLOGY INC

  公开号：WO2021127301A1

  公开（公告）日：2021-06-24

  4-phenyl-N-(phenyl)thiazol-2-amine and 4-(pyridin-3-yl)-N-( phenyl) thiazol-2-amine derivatives and the corresponding thiadiazole, thiophene, oxazole, oxadiazole, imidazole and triazole derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders.

  4-苯基-N-(苯基)噻唑-2-胺和4-(吡啶-3-基)-N-(苯基)噻唑-2-胺衍生物以及相应的噻二唑、噻吩、噁唑、噁二唑、咪唑和三唑衍生物和相关化合物作为芳香烃受体（AHR）激动剂，用于治疗涉及血管生成的疾病，例如视网膜病变、银屑病、类风湿性关节炎、肥胖和癌症，或炎症性疾病。